Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Karyopharm Therapeut (KPTI)

Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 126,948
  • Shares Outstanding, K 116,466
  • Annual Sales, $ 146,030 K
  • Annual Income, $ -143,100 K
  • 60-Month Beta 0.03
  • Price/Sales 0.87
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade KPTI with:

Options Overview Details

View History
  • Implied Volatility 135.23% ( +16.32%)
  • Historical Volatility 108.53%
  • IV Percentile 24%
  • IV Rank 6.19%
  • IV High 975.70% on 12/21/23
  • IV Low 79.81% on 03/15/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 109
  • Volume Avg (30-Day) 186
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 8,482
  • Open Int (30-Day) 10,831

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.33
  • Number of Estimates 4
  • High Estimate -0.28
  • Low Estimate -0.37
  • Prior Year -0.30
  • Growth Rate Est. (year over year) -10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0300 +2.91%
on 04/25/24
1.6500 -35.76%
on 04/01/24
-0.3300 (-23.74%)
since 03/25/24
3-Month
0.7505 +41.24%
on 01/31/24
1.9500 -45.64%
on 02/06/24
+0.1843 (+21.05%)
since 01/25/24
52-Week
0.6174 +71.69%
on 12/11/23
3.8650 -72.57%
on 05/01/23
-2.6900 (-71.73%)
since 04/25/23

Most Recent Stories

More News
Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript

KPTI earnings call for the period ending December 31, 2023.

KPTI : 1.0800 (-0.92%)
Karyopharm Therapeutics: Q4 Earnings Snapshot

Karyopharm Therapeutics: Q4 Earnings Snapshot

KPTI : 1.0800 (-0.92%)
Karyopharm Therapeutics (KPTI) Q3 2023 Earnings Call Transcript

KPTI earnings call for the period ending September 30, 2023.

KPTI : 1.0800 (-0.92%)
Karyopharm Therapeutics: Q3 Earnings Snapshot

Karyopharm Therapeutics: Q3 Earnings Snapshot

KPTI : 1.0800 (-0.92%)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

KPTI : 1.0800 (-0.92%)
Karyopharm to Present Selinexor Data at the 2023 International Myeloma Society Annual Meeting and European Society of Gynaecological Oncology 2023 Annual Meetings

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

KPTI : 1.0800 (-0.92%)
Karyopharm to Participate at Upcoming Investor Conferences

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

KPTI : 1.0800 (-0.92%)
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...

KPTI : 1.0800 (-0.92%)
Karyopharm Appoints Zhen Su, MD, MBA to its Board of Directors

/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the...

KPTI : 1.0800 (-0.92%)
Antengene Enters into Commercialization Partnership with Hansoh Pharma for First/Only-in-Class XPO1 Inhibitor XPOVIO®(selinexor) in the Mainland of China

- Antengene and Hansoh Pharma to enter into collaboration agreement involving commercialization of XPOVIO® in the mainland of China, broadening coverage and...

KPTI : 1.0800 (-0.92%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.

See More

Key Turning Points

3rd Resistance Point 1.2433
2nd Resistance Point 1.1967
1st Resistance Point 1.1433
Last Price 1.0800
1st Support Level 1.0433
2nd Support Level 0.9967
3rd Support Level 0.9433

See More

52-Week High 3.8650
Fibonacci 61.8% 2.6244
Fibonacci 50% 2.2412
Fibonacci 38.2% 1.8580
Last Price 1.0800
52-Week Low 0.6174

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar